antibody

Enterovirus 71

MBS604012

0.1 mL

610 USD

monoclonal

mouse

nonconjugated

2Q1930

Antibody

Enterovirus 71

Enterovirus 71

Anti -Enterovirus 71

Monoclonal

IgG1

2Q1930

Mouse

Coxsackie A16

Recognizes Enterovirus 71. Neutralizes enterovirus 71 BrCr strain at a titer of less than 1:14.

Ascites. Ascites

Supplied as a liquid

May be stored at 4 degree C for short-term only. For long-term storage, aliquot and store at -20 degree C. Aliquots are stable for 12 months at -20 degree C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.

Immunofluorescence (IF)

Suitable for use in Immunofluorescence. Dilution: Indirect Immunofluorescence: 1:1000 . Optimal dilutions to be determined by the researcher.

Immunogen: Whole viral lysate of Enterovirus 71

Antibodies; Abs to Infectious Disease Enterovirus

The enteroviruses are a genus of (+)ssRNA viruses associated with several human and mammalian diseases. Historically the most significant has been the Poliovirus. Other types are coxsackie and echovirus. Enterovirus are the most common cause of aseptic meningitis and can cause serious disease especially in infants and the immunocompromised. "Human enteroviruses (family Picornaviridae) infect millions of people worldwide each year, resulting in a wide range of clinical outcomes ranging from unapparent infection to mild respiratory illness (common cold), hand, foot and mouth disease, acute hemorrhagic conjunctivitis, aseptic meningitis, myocarditis, severe neonatal sepsis-like disease, and acute flaccid paralysis. In the United States, enteroviruses are responsible for 30,000 to 50,000 meningitis hospitalizations per year as a result of 30 million to 50 million infections. Serologic studies have distinguished 66 human enterovirus serotypes on the basis of an antibody neutralization test, and additional antigenic variants have been defined within several of the serotypes on the basis of reduced or nonreciprocal cross-neutralization between prototype and variant strains. On the basis of their pathogenesis in humans and experimental animals, the enteroviruses were originally classified into four groups, polioviruses, coxsackie A viruses (CA), coxsackie B viruses (CB), and echoviruses, but it was quickly realized that there were significant overlaps in the biological properties of viruses in the different groups. The more recently isolated enteroviruses have been named with a system of consecutive numbers: EV68, EV69, EV70, and EV71."[1] There "are 62 non-polio enteroviruses that can cause disease in humans: 23 Coxsackie A viruses, 6 Coxsackie B viruses, 28 echoviruses, and 5 other enteroviruses."[2]. EV71 was first isolated and characterized from cases of neurological disease in California in 1969.[7][8] "Enterovirus 71 (EV71), the newest member of Enterovirudae, is notable for its etiological role in epidemics of severe neurological diseases in children. It appears to be emerging as an important virulent neurotropic enterovirus in the upcoming era of poliomyelitis eradication".[9] The illness usually peaks in June or July. "Enterovirus 71 (EV71), one of the major causative agents for hand, foot, and mouth disease (HFMD), is sometimes associated with severe central nervous system dieseases. In 1997, in Malaysia and Japan, and in 1998 in Taiwan, there were HFMD epidemics involving sudden deaths among yound children, and EV71 was isolated from the HFMD patients, including the fatal cases. The nucleotide sequences of each EV71 isolate were recent epidemics could be divided into two genotypes, A-2 and B

0.1 mL

610 USD